logo Edap TMS
Français English US
  • EDAP TMS
    • La tradition de l'innovation
    • Activités d'EDAP TMS
    • EDAP TMS dans le monde
    • Management
    • Approche environnementale
  • Investisseurs
  • Produits & Services
    • Cancer de la prostate
      • Focal One
      • EXACTVU™
    • Adénome prostate
    • Calculs urinaires
      • Sonolith i-sys
      • Sonolith i-move
    • Services
      • Services HIFU
      • Services Lithotritie
      • Service Client
      • Formation
  • Information Clinique
    • Cancer de la prostate
    • Calculs urinaires
    • Etude Hemiablation
  • Presse
  • Carrières
    • Offres d'emploi
    • Candidature en ligne
Accueil  / 
Facebook picto   picto linkdink   picto tiwter

News

Nov 3, 2017
Dr. Bruno Nahar Interview - HIFU Prostate Treatment
EDAP-TMS

Watch Dr. Bruno Nahar Interview 

  • News
    • EDAP's HIFU Progress Is Obscured By The Pandemic, But It's Real
    • EDAP Announces Hiring of MedTech Industry Veteran Ryan Rhodes as CEO of Company’s U.S. Subsidiary
    • In the C-Suite with Marc Oczachowski, CEO, EDAP TMS
    • EDAP Selects Leading Reimbursement Consultancies MTP and Argenta Advisors to Expand Market Access and Coverage of HIFU in the US
    • The Future Is Now: Marc Oczachowski of EDAP TMS On How Their Technological Innovation Will Shake Up Healthcare
    • Positive 24 month interim results of French Urology Association (AFU) sponsored clinical trial study comparing HIFU to radical prostate surgery
    • By bringing a safe, ambulatory and non-invasive solution to patients with #prostate conditions, watch how EDAP TMS and #HIFU users are handling the situation with COVID-19 when elective procedures are currently being put on-hold.
    • Final US 2021 reimbursement rules for High Intensity Focused Ultrasound (HIFU)
    • First patients treated in phase 2 study of Focal One for the treatment of deep invasive endometriosis
    • Approval received for phase II study evaluating HIFU for deep invasive endometriosis
    • Two publications highlighting favorable HIFU focal therapy outcomes in journal of urology
    • Two publications highlighting favorable HIFU focal therapy outcomes in journal of urology
    • EDAP Announces Recent Focal One Sales Successes
    • EDAP announces exclusive worldwide distribution rights to EXACT Imaging's Micro-Ultrasound Technologies
    • B Riley FBR Initiates Research Coverage on EDAP TMS
    • EDAP TMS about COVID-19
    • Focal One's precision means qualifying prostate cancer patients can forego prostate removal surgery and avoid life-altering side effects including incontinence and impotence
    • Houston Methodist's Reinforces EDAP's Position as a Leading HIFU Innovator
    • Maimonides Medical Center acquires Focal One Technology
    • Two additional Focal One devices to two leading hospitals in Brazil
    • John Wayne Cancer Institute First US Medical Center to Acquire EDAP's Breakthrough Focal One Technology for Prostate Tissue Ablation
    • Oncology Live - Urologists in Cancer Care
    • As the Wife of a Prostate Cancer Survivor
    • A New Treatment for Localized Prostate Cancer Lets Men Keep the Sexual Passion in Their Relationships
    • Urologists, uro-oncologists and urology department chairs from renowned American universities will spend a day at Jewish General Hospital
    • HIFU Prostate Procedure Helps NASA Safety Engineer Protect His Health
    • EDAP TMS SA the global leader in therapeutic ultrasound, today announced the installation of the third Focal One device in Brazil at the renowned Albert Einstein Center of Oncology,
    • Prostate Cancer Leads Aerospace Biomedical Technician to Discover High-Tech HIFU
    • EDAP announces Installation of First Focal One HIFU device in South Korea
    • Alternative Treatment for Localized Prostate Cancer: Three Men’s Perspectives
    • Less-invasive prostate cancer treatment receives FDA clearance
    • Boomer Times Presents: Anita Finley with Clifford Gluck, MD, urologist
    • University of Miami at Forefront of Prostate Cancer Treatment
    • EDAP Announces FDA Clearance for Focal One
    • HIFU Procedure Keeps High School Ref in the Game after Prostate Cancer Diagnosis
    • Focal Ultrasound Prostate Ablation Shows Promising Results with Fewer Side Effects
    • Database to follow patients undergoing partial-gland HIFU
    • Point: Is HIFU for low-risk prostate Ca ready for prime time?
    • In a First, US Insurer Covers HIFU for Prostate Cancer
    • EDAP Reports First US Cohort Study Results of Focal HIFU Prostate Ablation Shows Promising Outcomes
    • New prostate cancer treatment found more effective than previous methods
    • New Prostate Cancer Treatment Is A Real Life Saver
    • Major US insurer to cover use of HIFU for treatment of radiorecurrent prostate cancer
    • EDAP Announces CIGNA as First Major U.S. Private Health Insurer to Cover HIFU for Prostate Procedure
    • Top Universities Join Forces to Launch First U.S. Based HIFU Patient Registry for Prostate Treatment
    • How to Build a Business Case for Medical Devices Awaiting Reimbursement
    • Focusing On You - Interview with Dr. Dipen Parekh
    • Men with Prostate Cancer May Not Know All of Their Treatment Options and Risks
    • They may have cancer. But they’ll be at the starting line.
    • New Medical Technology Gives Urologists a More Precise Method to Target Diagnosed Areas of the Prostate
    • Impact: Opio Speaks with Dr. Ivan Grunberger about Prostate Cancer
    • 30 secondes interview with Dr. Brian Miles on KTRH (iHeart Radio)
    • How to build a business case for medical devices awaiting reimbursement
    • Prostate cancer therapy gives patients a different approach
    • A Health Screening Saved My Life
    • Prostate Cancer 101: What All Senior Men Should Know
    • Arizona procedure could reduce side effects of prostate cancer treatment
    • Urologic Surgeons AZ Offer New Treatment for Prostate Cancer
    • Urologic Surgeons of Arizona to Offer New Option to Prostate Cancer Patients
    • What’s New in HIFU?
    • Deciding to Use HIFU for Prostate Cancer Treatment
    • Four Things Every Man Needs to Know after a Prostate Cancer Diagnosis
    • Dr. Bruno Nahar Interview - HIFU Prostate Treatment
    • Urologic Surgeons of Arizona offers new treatment for prostate cancer
    • Calls for Early Prostate Cancer Screening of Black Men May Get a Boost From HIFU Technology
    • Dr. Brian J. Miles interview
    • EDAP Announces Filing of New 510K
    • Vituro Health Adds Ablatherm Robotic HIFU
    • New Reimbursement Code for HIFU Ablation
    • Ablatherm at University of Minnesota
    • EDAP to Exclusively Distribute LABORIE's Medical Measurement Systems
    • Superior Outcomes of Focal Ablatherm-HIFU
    • Focal One(R) HIFU Sale to Foch Hospital, Paris
    • EDAP Receives the Prestigious Prix Galien
    • Ablatherm(R) Robotic HIFU Positioned as Efficient Option for Unilateral Prostate Ablation
    • Ablatherm Robotic(R) HIFU at Leading Academic Medical Center
    • First HIFU patient treated at Henry Ford Hospital in Detroit
    • First HIFU patient treated at Allied Urological Services in New York City
    • First Prostate Ablation Treatments Performed Using EDAP's FDA Approved Ablatherm® Robotic HIFU
    • EDAP Announces Results of World's First Focal HIFU Trial
    • EDAP Reports Sale of Ablatherm Robotic HIFU to Sylvester Comprehensive Cancer Center
    • EDAP Receives Russian Regulatory Approval for Focal One® HIFU Device
    • Installation of Ablatherm® Robotic HIFU at University of Southern California
    • EDAP Records First Three U.S. Orders for Ablatherm HIFU
    • Ablatherm FDA approved
    • Focal One® HIFU Device Adopted by Medipole Group in France
    • Focal One device in Switzerland
    • Focal One® HIFU at Germany's Martini-Klinik
    • First Focal One® HIFU Device in North America First Focal One® HIFU Device in North America
    • EDAP to Participate in Major
    • EDAP Announces Plans to Pursue Direct De Novo 510(k)
    • EDAP TMS SA today announced a multi-national strategic OEM partnership with Quanta System
    • Focal One HIFU Device Approved by Health Canada
    • EDAP Reports Continued Strong Growth in Third Quarter 2014
    • EDAP Receives FDA Guidance on PMA for Ablatherm-HIFU
    • EDAP Announces Sale of Focal One Nantes
    • EDAP Announces Sale of Focal One HIFU Device to Mannheim
    • Ablatherm HIFU Technology Highlighted
    • EDAP Completes FDA Inspection of Manufacturing Site
    • Reimbursement of HIFU
    • EDAP Completes FDA Q&A Session
    • NEWS-First Focal One's treatments in Poland
    • Arnaud Montebourg en visite à EDAP TMS

  • EDAP TMS
    • La tradition de l'innovation
    • Activités d'EDAP TMS
    • Carrières et offres d'emploi
    • Contact
  • Produits
    • Focal One®
    • ExactVU®
    • Sonolith i-move®
  • Services
    • Services HIFU
    • Services ESWL
  • Sites web EDAP TMS
    • EDAP TECHNOMED Japan
    • Site patient Hifu Prostate
    • EDAP TMS international
  • ©EDAP TMS 2014-2021
  • Mentions légales
  • Protection données personnelles
  • Politique de gestion des cookies
  • Contact
/fr/fr_news